Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.67 |
| ▸ | CES1 | P23141 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MMP8 | P22894 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27447197 | 0.85 | GSK3B (0.62) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL11510574 | 0.83 | GSK3B (0.71) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL240086 | 0.83 | GSK3B (0.71) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL220960 | 0.82 | GSK3B (0.69) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL11713734 | 0.82 | GSK3B (0.69) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL2867066 | 0.80 | GSK3B (0.67) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL6155163 | 0.80 | GSK3B (0.67) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL73490 | 0.80 | GSK3B (1.00) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL671514 | 0.80 | GSK3B (0.67) | GSK3BCES1CA1CA2TDP1 | |
| SCHEMBL255510 | 0.80 | GSK3B (0.67) | GSK3BCES1CA1CA2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103096892-B | Pharmaceutical composition containing carbamoyloxy group arylalkanoyl arylpiperazine compound | SK BIOPHARMACEUTICALS CO.,LTD. (KR) | 2015-08-12 | — | — | CN | disclosed |
| US-6107479-A | INTRODUCING A NONREMOVABLE LIPOPHILIC CAPPING GROUP TO AN UNREACTED REACTIVE GROUP OF OLIGOMER WHICH WAS NOT CHAIN EXTENDED IN PREVIOUS STEP, THEN SEPARATING CAPPED OLIGOMER FROM ELONGATED OLIGOMER ON A HYDROPHOBIC STATIONARY PHASE | NOVARTIS AG (CH) | 2000-08-22 | — | — | US | disclosed |
| WO-1998020018-A1 | PROCESS FOR THE PREPARATION OF AN OLIGOMERIC COMPOUND | NOVARTIS AG (CH) | 1998-05-14 | — | — | WO | disclosed |